Literature DB >> 6596953

[The antibacterial activity in vitro of ofloxacin in comparison with other orally administered antimicrobial substances on ampicillin-resistant clinical isolates].

G Seibert, N Klesel, M Limbert, E Schrinner, I Winkler.   

Abstract

The antibacterial activity of Ofloxacin (DL 8280, Hoe 280 Tarivid) against Ampicillin-resistant clinical isolates was compared to, Penicillin V, Tetracyclin-HCl, Cefalexin, Cefaclor, Co-trimoxazole and nalidixic acid. Ofloxacin proved to be the most active compound against all species tested.

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6596953

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN： 0004-4172


  7 in total

1.  [Tissue concentration and effectiveness of ofloxacin in surgical patients].

Authors:  W Düben; A Student; M Jablonski; R Malottke
Journal:  Infection       Date:  1986       Impact factor: 3.553

Review 2.  Fluorinated quinolones. A review of their mode of action, antimicrobial activity, pharmacokinetics and clinical efficacy.

Authors:  R Janknegt
Journal:  Pharm Weekbl Sci       Date:  1986-02-21

3.  Ofloxacin: concentration in human ejaculate and influence on sperm motility.

Authors:  P Schramm
Journal:  Infection       Date:  1986       Impact factor: 3.553

Review 4.  Ofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  J P Monk; D M Campoli-Richards
Journal:  Drugs       Date:  1987-04       Impact factor: 9.546

5.  Ofloxacin versus trimethoprim-sulphamethoxazole in acute cystitis.

Authors:  J M Block; R A Walstad; A Bjertnaes; P E Hafstad; M Holte; I Ottemo; P L Svarva; T Rolstad; L E Peterson
Journal:  Drugs       Date:  1987       Impact factor: 9.546

6.  [Ofloxacin treatment in nephrologic problem patients with various degrees of chronic renal failure (including dialysis treatment). Preliminary results].

Authors:  W Schulz; A Dörfler
Journal:  Infection       Date:  1986       Impact factor: 3.553

7.  Factors influencing the in vitro activity of two new aryl-fluoroquinolone antimicrobial agents, difloxacin (A-56619) and A-56620.

Authors:  L Hirschhorn; H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1986-07       Impact factor: 5.191
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.